Thomas Gamage, Ph.D.
Thomas Gamage, Ph.D.
Research Pharmacologist, Discovery Sciences, RTI International
Verified email at rti.org
Title
Cited by
Cited by
Year
Role of α5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice
KJ Jackson, MJ Marks, RE Vann, X Chen, TF Gamage, JA Warner, ...
Journal of Pharmacology and Experimental Therapeutics 334 (1), 137-146, 2010
1312010
Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Δ9-tetrahydrocannabinol
RE Vann, TF Gamage, JA Warner, EM Marshall, NL Taylor, BR Martin, ...
Drug and alcohol dependence 94 (1-3), 191-198, 2008
922008
Dual inhibition of endocannabinoid catabolic enzymes produces enhanced antiwithdrawal effects in morphine-dependent mice
D Ramesh, TF Gamage, T Vanuytsel, RA Owens, RA Abdullah, ...
Neuropsychopharmacology 38 (6), 1039-1049, 2013
442013
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569
TF Gamage, BM Ignatowska-Jankowska, JL Wiley, M Abdelrahman, ...
Behavioural pharmacology 25 (2), 182, 2014
432014
The endocannabinoid system: role in energy regulation
TF Gamage, AH Lichtman
Pediatric blood & cancer 58 (1), 144-148, 2012
322012
Molecular and behavioral pharmacological characterization of abused synthetic cannabinoids MMB-and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA
TF Gamage, CE Farquhar, TW Lefever, JA Marusich, RC Kevin, ...
Journal of Pharmacology and Experimental Therapeutics 365 (2), 437-446, 2018
242018
Thermolytic degradation of synthetic cannabinoids: chemical exposures and pharmacological consequences
BF Thomas, TW Lefever, RA Cortes, M Grabenauer, AL Kovach, AO Cox, ...
Journal of Pharmacology and Experimental Therapeutics 361 (1), 162-171, 2017
232017
Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice
TF Gamage, BM Ignatowska-Jankowska, PP Muldoon, BF Cravatt, ...
Drug and alcohol dependence 146, 7-16, 2015
222015
L-theanine attenuates abstinence signs in morphine-dependent rhesus monkeys and elicits anxiolytic-like activity in mice
LE Wise, ID Premaratne, TF Gamage, AH Lichtman, LD Hughes, ...
Pharmacology Biochemistry and Behavior 103 (2), 245-252, 2012
142012
The endogenous cannabinoid anandamide shares discriminative stimulus effects with∆ 9-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice
DM Walentiny, TF Gamage, JA Warner, TK Nguyen, DB Grainger, ...
European journal of pharmacology 656 (1-3), 63-67, 2011
142011
The great divide: separation between in vitro and in vivo effects of PSNCBAM-based CB1 receptor allosteric modulators
TF Gamage, CE Farquhar, TW Lefever, BF Thomas, T Nguyen, Y Zhang, ...
Neuropharmacology 125, 365-375, 2017
122017
Enhancement of the behavioral effects of endogenous and exogenous cannabinoid agonists by phenylmethyl sulfonyl fluoride
RE Vann, DM Walentiny, JJ Burston, KM Tobey, TF Gamage, JL Wiley
Neuropharmacology 62 (2), 1019-1027, 2012
122012
Comparative effects of dextromethorphan and dextrorphan on nicotine discrimination in rats
MJ Wright Jr, RE Vann, TF Gamage, MI Damaj, JL Wiley
Pharmacology Biochemistry and Behavior 85 (3), 507-513, 2006
112006
Synthetic cannabinoid hydroxypentyl metabolites retain efficacy at human cannabinoid receptors
TF Gamage, CE Farquhar, RJ McKinnie, RC Kevin, IS McGregor, ...
Journal of Pharmacology and Experimental Therapeutics 368 (3), 414-422, 2019
102019
Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN …
RC Kevin, AL Kovach, TW Lefever, TF Gamage, JL Wiley, IS McGregor, ...
Forensic toxicology 37 (1), 17-26, 2019
102019
Novel diarylurea based allosteric modulators of the cannabinoid CB1 receptor: evaluation of importance of 6-pyrrolidinylpyridinyl substitution
T Nguyen, N German, AM Decker, TL Langston, TF Gamage, ...
Journal of medicinal chemistry 60 (17), 7410-7424, 2017
102017
Sex, THC, and hormones: Effects on density and sensitivity of CB1 cannabinoid receptors in rats
CE Farquhar, CS Breivogel, TF Gamage, EA Gay, BF Thomas, RM Craft, ...
Drug and alcohol dependence 194, 20-27, 2019
92019
CB1 Allosteric Modulator Org27569 Is an Antagonist/Inverse Agonist of ERK1/2 Signaling
TF Gamage, JC Anderson, ME Abood
Cannabis and Cannabinoid Research 1 (1), 272-280, 2016
82016
Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1, 3, 4-oxadiazol-2-ones
ME Meza-Aviņa, MA Lingerfelt, LM Console-Bram, TF Gamage, H Sharir, ...
Bioorganic & medicinal chemistry letters 26 (7), 1827-1830, 2016
62016
Kinetic and metabolic profiles of synthetic cannabinoids NNEI and MN‐18
RC Kevin, TW Lefever, RW Snyder, PR Patel, TF Gamage, TR Fennell, ...
Drug testing and analysis 10 (1), 137-147, 2018
52018
The system can't perform the operation now. Try again later.
Articles 1–20